Candel Therapeutics CADL
NASDAQ CADL
$10.81 -0.07 (-0.64%)
As of: Sep 30, 2026 · 12:34 PM EDT

Candel Therapeutics, Inc. (CADL) Common Equity (2020 - 2026)

Updated

Candel Therapeutics' Common Equity came in at $126.13 million for Q2 2026, up 39.8% from $90.21 million a year earlier.

Analysis

Candel Therapeutics, Inc. (CADL) Common Equity (2020 - 2026) Analysis & Trends

At the end of FY2025, Candel Therapeutics' Common Equity was $51.92 million, down 21.7% from FY2024.

  • Going back by year, Common Equity was $66.33 million in FY2024 (+420.4%), $12.75 million in FY2023 (-73.3%), $47.71 million in FY2022 (-25.6%) and $64.14 million in FY2021.
  • The Q2 2026 figure represents the highest quarterly Common Equity in data going back to Q2 2020.
  • The fastest year-over-year change in Common Equity over five years came in Q4 2024 (growth of 420.4%), and the weakest in Q1 2024 (a decline of 84.9%).
Peer Set

Peer Comparison

Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 126.13 Mn
Dec 31, 2025 51.92 Mn
Sep 30, 2025 80.12 Mn
Jun 30, 2025 90.21 Mn
Mar 31, 2025 74.68 Mn
Dec 31, 2024 66.33 Mn
Sep 30, 2024 -15.26 Mn
Jun 30, 2024 -9.97 Mn
Mar 31, 2024 5.98 Mn
Dec 31, 2023 12.75 Mn
Sep 30, 2023 23.02 Mn
Jun 30, 2023 30.77 Mn
Mar 31, 2023 39.65 Mn
Dec 31, 2022 47.71 Mn
Sep 30, 2022 52.13 Mn
Jun 30, 2022 60.07 Mn
Mar 31, 2022 63.76 Mn
Dec 31, 2021 64.14 Mn
Sep 30, 2021 62.99 Mn
Jun 30, 2021 -43.18 Mn
API Access

Candel Therapeutics, Inc. Common Equity API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=common-equity&ticker=CADL&period=max&api_key=YOUR_API_KEY